$71.14
0.23[0.32%]
At close: Apr 19
$71.14
0[0.00%]
After Hours: 4:00PM EDT
Dr Reddy's Laboratories
(NYSE:RDY)Dr Reddy's Laboratories Stock (NYSE:RDY), Analyst Ratings, Price Targets, Predictions
Dr Reddy's Laboratories Ltd has a consensus price target of $80, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Barclays, and Barclays on January 29, 2024, June 1, 2023, and October 31, 2022. With an average price target of $72.33 between Barclays, Barclays, and Barclays, there's an implied 1.68% upside for Dr Reddy's Laboratories Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Dr Reddy's Laboratories
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/29/2024 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | 12.45% | Barclays | Balaji Prasad | $75 → $80 | Maintains | Overweight | Get Alert |
| 06/01/2023 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | -1.6% | Barclays | Balaji Prasad | $67 → $70 | Maintains | Overweight | Get Alert |
| 10/31/2022 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | -5.82% | Barclays | Balaji Prasad | $66 → $67 | Maintains | Overweight | Get Alert |
| 10/25/2022 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | -7.23% | Barclays | Balaji Prasad | $69 → $66 | Maintains | Overweight | Get Alert |
| 09/12/2022 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | -3.01% | Barclays | Balaji Prasad | $68 → $69 | Maintains | Overweight | Get Alert |
| 07/25/2022 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | -4.41% | Barclays | Balaji Prasad | $70 → $68 | Maintains | Overweight | Get Alert |
| 05/24/2022 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | -1.6% | Barclays | Balaji Prasad | $69 → $70 | Maintains | Overweight | Get Alert |
| 11/01/2021 | RDY | Buy Now | Dr Reddy's Laboratories | $71.14 | 12.45% | Barclays | Balaji Prasad | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Dr Reddy's Laboratories (RDY)?
The latest price target for Dr Reddy's Laboratories (NYSE: RDY) was reported by Barclays on January 29, 2024. The analyst firm set a price target for $80.00 expecting RDY to rise to within 12 months (a possible 12.45% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dr Reddy's Laboratories (RDY)?
The latest analyst rating for Dr Reddy's Laboratories (NYSE: RDY) was provided by Barclays, and Dr Reddy's Laboratories maintained their overweight rating.
When was the last upgrade for Dr Reddy's Laboratories (RDY)?
There is no last upgrade for Dr Reddy's Laboratories.
When was the last downgrade for Dr Reddy's Laboratories (RDY)?
There is no last downgrade for Dr Reddy's Laboratories.
When is the next analyst rating going to be posted or updated for Dr Reddy's Laboratories (RDY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dr Reddy's Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dr Reddy's Laboratories was filed on January 29, 2024 so you should expect the next rating to be made available sometime around January 29, 2025.
Is the Analyst Rating Dr Reddy's Laboratories (RDY) correct?
While ratings are subjective and will change, the latest Dr Reddy's Laboratories (RDY) rating was a maintained with a price target of $75.00 to $80.00. The current price Dr Reddy's Laboratories (RDY) is trading at is $71.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.